Table 3. Treatment outcome and its' Association with Baseline Characteristics.
Treatment Outcome | Mean Age (Year) | Male (n) | ALT (IU/L) | AST (IU/L) | Presence of Hepatomegaly (n) | Presence of Splenomegaly (n) | Presence of Palmar Erythema (n) | Presence of K-F Ring (n) | High Zinc Dose (n) | Mean Elemental Zinc (mg)/Day |
Quick Response (n = 21) | 6.6 | 14 | 166 | 115 | 12 | 2 | 4 | 1 | 16 | 117 |
Slow/No Response (n = 9) | 6.6 | 7 | 228 | 140 | 5 | 0 | 5 | 0 | 6 | 130 |
P Value | 0.99 | 0.68 | 0.16 | 0.35 | 1.00 | 1.00 | 0.08 | 1.00 | 0.67 | 0.39 |